Ernest Mario - 21 May 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 May 2024, 19:11:13 UTC
Prior SEC filing
10 Jan 2024
Next SEC filing
10 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anish Bhatnagar, Attorney-in-Fact

Key filing fact

Ernest Mario filed Form 4 for SOLENO THERAPEUTICS INC (SLNO) on 23 May 2024.

Key facts

  • This page summarizes Ernest Mario's Form 4 filing for SOLENO THERAPEUTICS INC (SLNO).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 23 May 2024, 19:11.

Change

  • Previous filing in this sequence was filed on 10 Jan 2024.
  • Current net transaction value: +$279,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLNO transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
$279,000
Shares
+62,000
Change %
+50%
Price
$4.50
Shares after
186,566
Date
21 May 2024
Ownership
Direct
SLNO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,789
Date
21 May 2024
Ownership
See footnote
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLNO transaction Derivative

Warrant (right to buy)

Exercise of in-the-money or at-the-money derivative security

Transaction value
$0
Shares
-62,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
21 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
62,000
Exercise price
$4.50
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The number of shares beneficially owned has been adjusted pursuant to an internal review of the Reporting Person's holdings.

Footnote F2

The shares are held by Mildred Mario Nonexempt Trust, of which the Reporting Person is a co-trustee.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .